Inactive Instrument
Isodiol International Inc Share Price Canadian Securities Exchange
Stocks
CA46500L1013
Pharmaceuticals
OTC Markets Traded| Market Cap | 39.11L 28.41L 24.33L 22.77L 20.84L 27Cr 39.63L 2.69Cr 1.05Cr 14Cr 1.07Cr 1.04Cr 45Cr | P/E 2018 |
-4.94x | P/E 2019 | -0.37x |
|---|---|---|---|---|---|
| Enterprise Value | 91.33L 66.33L 56.82L 53.17L 48.67L 63Cr 92.54L 6.28Cr 2.45Cr 32Cr 2.49Cr 2.44Cr 105.45Cr | EV / Sales 2018 |
12.6x | EV / Sales 2019 | 2.48x |
| Free-Float |
100% | Yield 2018 * |
-
| Yield 2019 | - |
| 1 day | -3.58% |
| Manager | Title | Age | Since |
|---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/2017 |
Andrew Alvis
DFI | Director of Finance/CFO | - | - |
| Corporate Officer/Principal | - | 30/08/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Marcos Agramont
BRD | Director/Board Member | - | 24/05/2017 |
| Director/Board Member | - | 30/08/2018 | |
| Director/Board Member | - | 21/11/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.58% | +881.08% | - | - | 128 | |
| -1.75% | -1.40% | -14.42% | -5.80% | 1.31TCr | |
| -2.74% | -2.90% | -35.91% | -58.08% | 484.94Cr | |
| -6.30% | -6.88% | -7.32% | -6.01% | 459.02Cr | |
| -5.35% | -3.01% | +1.29% | -26.92% | 408.83Cr | |
| -2.56% | -2.27% | -24.04% | +2.40% | 350.99Cr | |
| -2.87% | -0.49% | -11.37% | -6.48% | 334.39Cr | |
| -3.23% | -2.35% | -12.30% | +13.41% | 332.69Cr | |
| -4.14% | -2.45% | -18.19% | -14.63% | 243.47Cr | |
| -3.92% | -3.50% | -30.34% | -13.28% | 167.47Cr | |
| Average | -3.64% | -2.70% | -16.96% | -12.82% | 454.57Cr | |
| Weighted average by Cap. | -3.25% | -2.35% | -15.88% | -12.75% |
| 2018 | 2019 | |
|---|---|---|
| Net sales | 1.91Cr 1.39Cr 1.19Cr 1.11Cr 1.02Cr 132.98Cr 1.94Cr 13Cr 5.13Cr 67Cr 5.22Cr 5.11Cr 220.96Cr | 2.22Cr 1.62Cr 1.38Cr 1.3Cr 1.19Cr 154.6Cr 2.25Cr 15Cr 5.97Cr 78Cr 6.07Cr 5.94Cr 256.87Cr |
| Net income | -3.6Cr -2.62Cr -2.24Cr -2.1Cr -1.92Cr -250.3Cr -3.65Cr -25Cr -9.66Cr -125.74Cr -9.82Cr -9.61Cr -415.89Cr | -13Cr -9.14Cr -7.83Cr -7.33Cr -6.71Cr -874.95Cr -13Cr -87Cr -34Cr -439.53Cr -34Cr -34Cr -1.45TCr |
| Net Debt | -1.55Cr -1.13Cr -96.74L -90.51L -82.86L -108.05Cr -1.58Cr -11Cr -4.17Cr -54Cr -4.24Cr -4.15Cr -179.53Cr | 52.22L 37.93L 32.49L 30.4L 27.83L 36Cr 52.91L 3.59Cr 1.4Cr 18Cr 1.42Cr 1.39Cr 60Cr |
Employees
-
Sector
Pharmaceuticals
